Search - tctmd.com

Displaying 201 - 220 of 258

Sort: Relevancy | Date

News Conference News TCT 2014

Experts Debate Future of Renal Denervation

September 16, 2014

Presentation TCT 2014

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Conference News TCT 2014

Expert Discusses Potential Role for Platelet Function, Genetic Testing

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Conference News TCT 2014

AUC ‘Here to Stay’ but Should Evolve, Expert Says

September 15, 2014

Presentation TCT 2014

Resistant Hypertension!

Presenter: Atul Pathak

September 14, 2014

Presentation TCT 2014

Early Stage or Uncontrolled Hypertension!

Presenter: Darrel P. Francis

September 14, 2014

Presentation TCT 2014

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Antonios Karanasos

September 14, 2014

Presentation TCT 2014

Updates and Status of the Cordis Renlane Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Felix Mahfoud

September 14, 2014

Presentation TCT 2014

Updates and Status of the ReCor Paradise Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Thomas Zeller

September 14, 2014

Presentation TCT 2014

Updates and Status of the St. Jude EnligHTN Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm

September 14, 2014

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

Advertisement

Experts Debate Future of Renal Denervation

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

Expert Discusses Potential Role for Platelet Function, Genetic Testing

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

AUC ‘Here to Stay’ but Should Evolve, Expert Says

Resistant Hypertension!

Early Stage or Uncontrolled Hypertension!

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Updates and Status of the Cordis Renlane Program

Updates and Status of the ReCor Paradise Program

Updates and Status of the St. Jude EnligHTN Program

Updates and Status of the Boston Scientific Vessix Program

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Experts Debate Future of Renal Denervation Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content